Li Y, Chen P, Huang X, Huang H, et al. Corrigendum to "Pathogenic Th17 cells are a potential therapeutic target for tacrolimus in AChR-myasthenia gravis patients" [Journal of Neuroimmunology. 2024 Nov 15:396:578464]. J Neuroimmunol 2025 Jan 16:578526. doi: 10.1016/j.jneuroim.2025.578526.
PMID: 39924423